1-((2R,3R,4S,5S)-5-((S)-1-((2R,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxytetrahydrofuran-2-yloxy)-2-(1-(4-((4-benzoylphenoxy)methyl)benzyl)-1H-1,2,3-triazol-4-yl)ethyl)-3,4-dihydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

ID: ALA4521972

Chembl Id: CHEMBL4521972

PubChem CID: 155542874

Max Phase: Preclinical

Molecular Formula: C38H40N6O11

Molecular Weight: 756.77

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  NC[C@H]1O[C@@H](O[C@@H](Cc2cn(Cc3ccc(COc4ccc(C(=O)c5ccccc5)cc4)cc3)nn2)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C38H40N6O11/c39-17-28-31(47)34(50)37(54-28)53-27(35-32(48)33(49)36(55-35)44-15-14-29(45)40-38(44)51)16-25-19-43(42-41-25)18-21-6-8-22(9-7-21)20-52-26-12-10-24(11-13-26)30(46)23-4-2-1-3-5-23/h1-15,19,27-28,31-37,47-50H,16-18,20,39H2,(H,40,45,51)/t27-,28+,31+,32-,33+,34+,35+,36+,37+/m0/s1

Standard InChI Key:  BFQARAORPOXDHX-BQKAZMJOSA-N

Alternative Forms

  1. Parent:

    ALA4521972

    ---

Associated Targets(non-human)

mraY Phospho-N-acetylmuramoyl-pentapeptide-transferase (26 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Citrobacter freundii (1864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus faecium (13803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
mraY Phospho-N-acetylmuramoyl-pentapeptide-transferase (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 756.77Molecular Weight (Monoisotopic): 756.2755AlogP: -0.36#Rotatable Bonds: 14
Polar Surface Area: 246.50Molecular Species: BASEHBA: 16HBD: 6
#RO5 Violations: 3HBA (Lipinski): 17HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.70CX Basic pKa: 8.75CX LogP: 0.95CX LogD: -0.17
Aromatic Rings: 5Heavy Atoms: 55QED Weighted: 0.08Np Likeness Score: 0.11

References

1. Patel B, Ryan P, Makwana V, Zunk M, Rudrawar S, Grant G..  (2019)  Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.,  171  [PMID:30933853] [10.1016/j.ejmech.2019.01.071]
2. Serpi M, Ferrari V, Pertusati F..  (2016)  Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?,  59  (23): [PMID:27607900] [10.1021/acs.jmedchem.6b00325]

Source